Suton P, Salaric I, Granic M, Mueller D, Luksic I
Division of Radiation Oncology, Department of Radiotherapy and Medical Oncology, University Hospital for Tumours, University Hospital Centre "Sisters of Mercy", Zagreb, Croatia.
Division of Oral Surgery, Department of Maxillofacial Surgery, University of Zagreb School of Dental Medicine, University Hospital Dubrava, Zagreb, Croatia.
Int J Oral Maxillofac Surg. 2017 Jun;46(6):669-675. doi: 10.1016/j.ijom.2017.02.1277. Epub 2017 Mar 25.
The presence of extracapsular spread (ECS) in patients with oral squamous cell carcinoma (OSCC) indicates a poor prognosis and is associated with a higher risk of regional recurrence and distant metastasis. The aim of this study was to analyse this important feature of cervical lymph nodes in the clinically node-negative setting. The study included 61 patients with clinically T1-T3N0 OSCC who underwent primary surgical treatment; 52 were male and nine were female, and their median age was 57 years. The 5-year disease-free survival, disease-specific survival, and overall survival rates were 30.6%, 28.3%, and 14.3%, respectively, in the ECS group compared to 61.9%, 61.9%, and 48.2%, respectively, in the pN+/ECS-negative group and 76.7%, 81.9%, and 47.0%, respectively, in the pN0 group. The differences between the survival curves were highly significant (P=0.023, P=0.003, and P=0.029, respectively). The incidence of local (50% vs. 14.9%, P=0.011) and regional (28.6% vs. 2.1%, P=0.008) recurrence was significantly greater in the ECS group compared to the other subgroups of patients. Furthermore, the time to recurrence was significantly shorter in the ECS subjects. The presence of ECS in patients with oral cancer indicates a poor prognosis. ECS is a frequent feature in clinically node-negative settings and may be more common in smaller lymph nodes than is generally appreciated.
口腔鳞状细胞癌(OSCC)患者出现包膜外扩散(ECS)提示预后不良,且与区域复发和远处转移的较高风险相关。本研究的目的是分析临床淋巴结阴性情况下颈部淋巴结的这一重要特征。该研究纳入了61例接受初次手术治疗的临床T1-T3N0 OSCC患者;其中52例为男性,9例为女性,中位年龄为57岁。ECS组的5年无病生存率、疾病特异性生存率和总生存率分别为30.6%、28.3%和14.3%,相比之下,pN+/ECS阴性组分别为61.9%、61.9%和48.2%,pN0组分别为76.7%、81.9%和47.0%。生存曲线之间的差异具有高度显著性(分别为P=0.023、P=0.003和P=0.029)。与其他患者亚组相比,ECS组的局部复发(50%对14.9%,P=0.011)和区域复发(28.6%对2.1%,P=0.008)发生率显著更高。此外,ECS患者的复发时间显著更短。口腔癌患者中ECS的存在提示预后不良。ECS是临床淋巴结阴性情况下的常见特征,在较小淋巴结中可能比一般认为的更常见。